This list is an analysis based on recent market events. It's not an investment recommendation.
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
FAQs
What is GeneTether Therapeutics stock price today?▼
The current price of GTTX.CN is C$0.12 CAD — it has increased by +0% in the past 24 hours. Watch GeneTether Therapeutics stock price performance more closely on the chart.
What is GeneTether Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange GeneTether Therapeutics stocks are traded under the ticker GTTX.CN.
What is GeneTether Therapeutics market cap?▼
Today GeneTether Therapeutics has the market capitalization of 9.69M
What is GeneTether Therapeutics revenue for the last year?▼
GeneTether Therapeutics revenue for the last year amounts to 0 CAD.
What is GeneTether Therapeutics net income for the last year?▼
GTTX.CN net income for the last year is -1.72M CAD.
In which sector is GeneTether Therapeutics located?▼
GeneTether Therapeutics operates in the Health & Wellness sector.
When did GeneTether Therapeutics complete a stock split?▼
GeneTether Therapeutics has not had any recent stock splits.
Where is GeneTether Therapeutics headquartered?▼
GeneTether Therapeutics is headquartered in Kelowna, Canada.